A more crowded space is presenting new challenges for stakeholders that must be addressed to improve efficiency.
Matt Latey
Advertisement
Vice President, Head of Development Operations-Biopharma, PPD Clinical Research, Thermo Fisher Scientific
Articles by Matt Latey
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
How AI Is Changing Endpoint Selection Before a Trial Even Starts
2
The Design Flaws Trial Simulations Surface That Traditional Planning Misses
3
Sponsor Oversight in an Outsourced Trial: What Good Looks Like and How to Evidence It
4
ACT Brief: AI Expands Endpoint Options, CRO Oversight Documentation, and Kidney Cancer Approval
5